相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Current therapies and new developments in NASH
Jean-Francois Dufour et al.
GUT (2022)
Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease
Nikhil Y. Patil et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
Marica Cariello et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice
Xiuxiu Xu et al.
FRONTIERS IN NUTRITION (2021)
Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice
Michal Weitman et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
The aryl hydrocarbon receptor in liver inflammation
Antonella Carambia et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
Naim Alkhouri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Guido Carpino et al.
HEPATOLOGY (2020)
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Joost Boeckmans et al.
CELLS (2020)
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
Anna Permyakova et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease
Silvana Y. Romero-Zerbo et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada et al.
CELL DEATH & DISEASE (2020)
Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
Sara Della Torre
FRONTIERS IN ENDOCRINOLOGY (2020)
Farnesoid X Receptor Agonism, Acetyl-Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model
Berangere Gapp et al.
HEPATOLOGY COMMUNICATIONS (2020)
Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
Qunyan Yao et al.
FRONTIERS IN MEDICINE (2020)
New dual peroxisome proliferator activated receptor agonistSaroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
Upendra Kaul et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice
Jiong Yan et al.
GASTROENTEROLOGY (2019)
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell et al.
HEPATOLOGY (2019)
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
Li Chen et al.
FRONTIERS IN ONCOLOGY (2019)
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Verena Hiebl et al.
BIOTECHNOLOGY ADVANCES (2018)
A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway
Lichen Bao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Cristina Gutierrez-Vazquez et al.
IMMUNITY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents
Shani Zeeli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease
Maria E. Moreno-Fernandez et al.
JCI INSIGHT (2018)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Indoline derivatives mitigate liver damage in a mouse model of acute liver injury
Efrat Finkin-Groner et al.
PHARMACOLOGICAL REPORTS (2017)
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Schohraya Spahis et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation
Eun Jung Park et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
Mei Xiang et al.
JOURNAL OF HEPATOLOGY (2016)
Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1
Benjamin J. Moyer et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling
Robert Caesar et al.
CELL METABOLISM (2015)
Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21
Peipei Lu et al.
HEPATOLOGY (2015)
Liver fibrosis markers of nonalcoholic steatohepatitis
Hirayuki Enomoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
Rui-Ming Liu et al.
REDOX BIOLOGY (2015)
Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages
Svetlana Furman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Josef Ehling et al.
GUT (2014)
The roles of aryl hydrocarbon receptor in immune responses
Nam Trung Nguyen et al.
INTERNATIONAL IMMUNOLOGY (2013)
The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease
Mi-Hyun Kim et al.
BRITISH JOURNAL OF NUTRITION (2010)
Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
Zhao-Xia Yang et al.
HEPATOLOGY INTERNATIONAL (2010)
分享论文
